Literature DB >> 12735719

Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model.

Xunde Li1, Philippe Brasseur, Patrice Agnamey, Denis Leméteil, Loïc Favennec, Jean-Jacques Ballet, Jean-François Rossignol.   

Abstract

Cryptosporidium parvum, Tyzzer, 1912 is identified as a common cause of diarrhoea in immunocompetent individuals. In immunocompromised, especially HIV-infected subjects, cryptosporidiosis causes severe chronic diarrhoea. In this study, nitazoxanide (NTZ) was compared for curative activity with sinefungin (SNF) and paromomycin (PRM) in immunosuppressed rats, a screening model for anticryptosporidial agents. NTZ at either 50 mg/kg/day, 100 mg/kg/day or 200 mg/kg/day resulted in seven days in a dose-dependent inhibition of oocyst shedding similar to that obtained with SNF (10 mg/kg/day) and PRM (100 mg/kg/day). Further discontinuation of SNF or PRM 100 mg/kg/day therapy resulted in early relapse of oocyst shedding which reached the pre-treatment levels in 2-4 days. In contrast, seven days after discontinuation of therapy, shedding inhibition was unchanged in NTZ-treated rats. Data prompt further assessment of the activity of NTZ on sequestered C. parvum.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12735719     DOI: 10.14411/fp.2003.003

Source DB:  PubMed          Journal:  Folia Parasitol (Praha)        ISSN: 0015-5683            Impact factor:   2.122


  12 in total

1.  Transient neonatal Cryptosporidium parvum infection triggers long-term jejunal hypersensitivity to distension in immunocompetent rats.

Authors:  Rachel Marion; Asiya Baishanbo; Gilles Gargala; Arnaud François; Philippe Ducrotté; Celia Duclos; Jean Fioramonti; Jean Jacques Ballet; Loïc Favennec
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

2.  Infectivity of Cryptosporidium hominis and Cryptosporidium parvum genotype 2 isolates in immunosuppressed Mongolian gerbils.

Authors:  Asiya Baishanbo; Gilles Gargala; Agnès Delaunay; Arnaud François; Jean-Jacques Ballet; Loïc Favennec
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.

Authors:  Howayda Said Fouad Moawad; Mohamed Hegab Abd El-Hady Hegab; Maha Saber Reda Badawey; Shaimaa Elsayed Ashoush; Shereen Mahmoud Ibrahim; Amira Abd El-Lateef Saleh Ali
Journal:  J Parasit Dis       Date:  2021-01-06

4.  Deep glance on the antiparasitic anticancer activities of wheat germ oil in chronically infected immunosuppressed mice with cryptosporidiosis.

Authors:  Hagar F Abdelmaksoud; Tarek S Aboushousha; Ayman M El-Ashkar
Journal:  J Parasit Dis       Date:  2022-06-02

5.  Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates.

Authors:  Henri Viel; Hélène Rocques; Jennifer Martin; Christophe Chartier
Journal:  Parasitol Res       Date:  2007-09-15       Impact factor: 2.289

Review 6.  Nitazoxanide: a review of its use in the treatment of gastrointestinal infections.

Authors:  Vanessa R Anderson; Monique P Curran
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination.

Authors:  Lucienne Tritten; Angelika Silbereisen; Jennifer Keiser
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2012-03-10       Impact factor: 4.077

8.  Evaluation of possible prophylactic and therapeutic effect of mefloquine on experimental cryptosporidiosis in immunocompromised mice.

Authors:  Eman S El-Wakil; Amal E Salem; Asmaa M F Al-Ghandour
Journal:  J Parasit Dis       Date:  2020-11-13

9.  Identification of PPARγ ligands with One-dimensional Drug Profile Matching.

Authors:  Diána Kovács; Zoltán Simon; Péter Hári; András Málnási-Csizmadia; Csaba Hegedűs; László Drimba; József Németh; Réka Sári; Zoltán Szilvássy; Barna Peitl
Journal:  Drug Des Devel Ther       Date:  2013-09-02       Impact factor: 4.162

10.  Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.

Authors:  M Schnyder; L Kohler; A Hemphill; P Deplazes
Journal:  Vet Parasitol       Date:  2008-11-05       Impact factor: 2.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.